Select a section from the left sidebar
16-hydroxyhexadecanoic acid methyl ester
- Family: Plantae - Fagaceae
- Kingdom: Plantae
-
Class: Fatty Acid
- Subclass: Omega-Hydroxy Fatty Acid
Canonical Smiles | OCCCCCCCCCCCCCCCC(=O)OC |
---|---|
InChI | InChI=1S/C17H34O3/c1-20-17(19)15-13-11-9-7-5-3-2-4-6-8-10-12-14-16-18/h18H,2-16H2,1H3 |
InChIKey | AOTMRIXFFOGWDT-UHFFFAOYSA-N |
Formula | C17H34O3 |
HBA | 3 |
HBD | 1 |
MW | 286.46 |
Rotatable Bonds | 15 |
TPSA | 46.53 |
LogP | 4.61 |
Number Rings | 0 |
Number Aromatic Rings | 0 |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Fraction CSP3 | 0.94 |
Exact Mass | 286.25 |
Number of Lipinski Rule Violations | 0 |
# | Species | Family | Kingdom | NCBI Taxonomy ID |
---|---|---|---|---|
1 | Quercus suber | Fagaceae | Plantae | 58331 |
Showing of synonyms
16-hydroxyhexadecanoic acid methyl ester
Methyl 16-hydroxyhexadecanoate
36575-67-4
Hexadecanoic acid, 16-hydroxy-, methyl ester
Melanocortin-4 Receptor antagonist
SCHEMBL1245383
Methyl 16-hydroxy-hexadecanoate
DTXSID80393043
MFCD30473263
AKOS005066798
AS-84393
DB-114603
CS-0091027
D85272
No compound-protein relationship available.
No scaffolds available.
No bioactivities available.
Absorption
- Caco-2 (logPapp)
- -4.89
- Human Oral Bioavailability 20%
- Non-Bioavailable
- Human Intestinal Absorption
- Absorbed
- Madin-Darby Canine Kidney
- -3.59
- Human Oral Bioavailability 50%
- Non-Bioavailable
- P-Glycoprotein Inhibitor
- Non-Inhibitor
- P-Glycoprotein Substrate
- Non-Substrate
- Skin Permeability
- -3.61
Distribution
- Blood-Brain Barrier (CNS)
- -
- Blood-Brain Barrier
- Penetrable
- Fraction Unbound (Human)
- 1.33
- Plasma Protein Binding
- 21.8
- Steady State Volume of Distribution
- -
Metabolism
- Breast Cancer Resistance Protein
- Non-Inhibitor
- CYP 1A2 Inhibitor
- Inhibitor
- CYP 1A2 Substrate
- Non-Substrate
- CYP 2C19 Inhibitor
- Non-Inhibitor
- CYP 2C19 Substrate
- Non-Substrate
- CYP 2C9 Inhibitor
- Non-Inhibitor
- CYP 2C9 Substrate
- Non-Substrate
- CYP 2D6 Inhibitor
- Non-Inhibitor
- CYP 2D6 Substrate
- Non-Substrate
- CYP 3A4 Inhibitor
- Non-Inhibitor
- CYP 3A4 Substrate
- Non-Substrate
- OATP1B1
- Non-Inhibitor
- OATP1B3
- Non-Inhibitor
Excretion
- Clearance
- 6.68
- Organic Cation Transporter 2
- Non-Inhibitor
- Half-Life of Drug
- -
Toxicity
- AMES Mutagenesis
- Safe
- Avian
- Safe
- Bee
- Safe
- Bioconcentration Factor
- 1.37
- Biodegradation
- Toxic
- Carcinogenesis
- Safe
- Crustacean
- Toxic
- Liver Injury I (DILI)
- Safe
- Eye Corrosion
- Toxic
- Eye Irritation
- Toxic
- Maximum Tolerated Dose
- 2.2
- Liver Injury II
- Safe
- hERG Blockers
- Safe
- Daphnia Maga
- 3.89
- Micronucleos
- Safe
- NR-AhR
- Safe
- NR-AR
- Safe
- NR-AR-LBD
- Safe
- NR-Aromatase
- Safe
- NR-ER
- Safe
- NR-ER-LBD
- Safe
- NR-GR
- Safe
- NR-PPAR-gamma
- Safe
- NR-TR
- Safe
- T. Pyriformis
- 5.66
- Rat (Acute)
- 1.45
- Rat (Chronic Oral)
- 2.47
- Fathead Minnow
- 3.93
- Respiratory Disease
- Safe
- Skin Sensitisation
- Toxic
- SR-ARE
- Safe
- SR-ATAD5
- Safe
- SR-HSE
- Safe
- SR-MMP
- Safe
- SR-p53
- Safe
General Properties
- Boiling Point
- 365.61
- Hydration Free Energy
- -3.26
- Log(D) at pH=7.4
- 4.06
- Log(P)
- 5.52
- Log S
- -5.62
- Log(Vapor Pressure)
- -5.96
- Melting Point
- 56.46
- pKa Acid
- 11.91
- pKa Basic
- 5.02
No predicted protein targets found for this compound.